Previous Article | Next Article 
Molecular and Cellular Biology, August 2000, p. 5631-5642, Vol. 20, No. 15
0270-7306/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Characterization and Targeted Disruption of Murine
Nup50, a p27Kip1-Interacting Component of the Nuclear
Pore Complex
Matthew
Smitherman,1,2
Keesook
Lee,1,3
Jherek
Swanger,1,2
Raj
Kapur,4 and
Bruce E.
Clurman1,2,5,*
Clinical Research1 and Human
Biology2 Divisions, Fred Hutchinson Cancer
Research Center, Seattle, Washington, 98109; Departments of
Pathology4 and
Medicine,5 University of Washington,
Seattle, Washington 98104; and Hormone Research Center,
Chonnam National University, Kwangju 500-757, Korea3
Received 1 February 2000/Returned for modification 7 March
2000/Accepted 25 April 2000
 |
ABSTRACT |
p27Kip1 is a member of the Cip-Kip family of
cyclin-dependent kinase (Cdk) inhibitors that binds to cyclin-Cdk
complexes and inhibits their catalytic activity in response to
antiproliferative stimuli. p27Kip1 is regulated by several
posttranscriptional mechanisms, including subcellular localization. We
have identified a component of the nuclear pore complex (NPC), termed
Nup50, through its two-hybrid interactions with p27Kip1.
Nup50 is a nucleoplasmically oriented component of the nuclear pore
complex with a role in protein export (T. Guan, R. H. Kehlenbach, E. C. Schirmer, A. Kehlenbach, F. Fan, B. E. Clurman, N. Arnheim, and L. Gerace, Mol. Cell. Biol. 20:5619-5630, 2000). We found that murine
Nup50 is a widely expressed nucleoporin and that Nup50 expression is
highest in the developing neural tube and adult testes. We have also
examined interactions between Nup50 and the NPC and found specific
two-hybrid interactions between Nup50 and several well-defined
components of the NPC, as well as coimmunoprecipitation of Nup50 with
the nucleoporin Nup153 from transfected mammalian cells. In order to
study Nup50 function in vivo, we cloned the mouse Nup50 genomic locus
and created a targeted Nup50 deletion in the mouse germ line. Nup50
disruption resulted in a complex phenotype characterized by late
embryonic lethality, neural tube defects, and intrauterine growth
retardation. Although Nup50-null mouse embryo fibroblasts exhibited no
defects in either cell cycle control or p27Kip1 regulation,
Nup50 deletion was associated with abnormalities in p27Kip1
expression and cell proliferation in the developing neuroepithelium. We
conclude that Nup50 is a nucleoporin with essential functions during
mouse development.
 |
INTRODUCTION |
The nucleocytoplasmic transport of
macromolecules is regulated by the nuclear pore complex (NPC) (reviewed
in references 5, 16, and 18). The
NPC is a large structure comprised of a symmetrical core embedded
within the nuclear envelope and extensive 50- to 100-nm filaments that
project into both the nucleus and cytoplasm (8, 20). The NPC
contains more than 50 different proteins, termed nucleoporins, some of
which have been assigned specific NPC locations and/or functions. Many
nucleoporins share sequence and structural motifs, including repeated
peptides (FXFG or GLFG) in regions that mediate interactions with
soluble transport factors, coiled-coiled domains involved in
interactions between some nucleoporins, and modification with
O-linked N-acetylglucosamine in higher eukaryotes.
All macromolecular traffic between the nucleus and cytoplasm passes
through the NPC (9, 18). Molecules smaller than 20 to 40 kDa
can traverse the NPC via a diffusion channel. In contrast, the
transport of larger molecules, termed cargo, is mediated by specific
transport receptors. In general, proteins destined for import are bound
by transport receptors that recognize specific sequence signals and
then are brought through the NPC, followed by cargo release and
receptor protein recycling. This process also requires the GTPase Ran.
The known import receptors are a family of distantly related proteins
specialized for different types of cargo and transport signals. The
prototype import receptor is the importin
/importin
complex
involved in importing proteins with classic basic nuclear localization
signals (NLS). Protein export pathways are less well characterized,
although one major export pathway has been extensively studied and
involves the export of cargo that contain leucine rich nuclear export
signals (NES) via the transport receptor Crm1 (reviewed in reference
32).
Many cellular processes depend upon NPC function. In some cases, such
as protein synthesis, the role of the NPC in transporting large amounts
of mRNA and ribosomes is obvious. However, nucleocytoplasmic transport
also plays important regulatory roles in processes such as cell cycle
control (reviewed in references 21 and
37). For example, in mammalian cells cyclin B1 is
sequestered in the cytoplasm during most of the cell cycle by a
Crm1-dependent export mechanism and enters the nucleus only at the
G2/M boundary (11, 36). Subcellular
compartmentalization has also been reported to regulate the function
and stability of the p27Kip1 protein. p27Kip1
is a member of the Cip-Kip family of cyclin-dependent kinase (Cdk)
inhibitors and inhibits the cell cycle by binding to Cdks in response
to various antimitogenic signals (25). Cyclin-Cdks function
in the nucleus, and p27Kip1 binds and inhibits cyclin-Cdks
in the nucleus as well (22). The stability of
p27Kip1 may also be regulated by its subcellular location
(reviewed in reference 3). For example, the Jab1
protein may promote p27Kip1 export and cause it to be
degraded in the cytoplasm (30). Cytoplasmic mislocalization
of p27Kip1 has also been described in tumor cells, and it
has been suggested that cytoplasmic sequestration may functionally
inactivate p27Kip1 in some tumor cells (19, 26).
In this study we report the characterization of a NPC-associated
protein originally termed npap60 and now renamed Nup50 (10) that we identified through a two-hybrid interaction with
p27Kip1. Nup50 was initially described as a rat NPC protein
that undergoes unusual changes in localization during male germ cell
differentiation (6). We have found that Nup50 is a
ubiquitously expressed NPC protein that exhibited two-hybrid
interactions with multiple transport receptor proteins and
coimmunoprecipitated with the nucleoporin Nup153. We have also cloned
and characterized the mouse genomic Nup50 locus and created a targeted
Nup50 deletion in the mouse germ line. Deletion of Nup50 caused
embryonic lethality associated with neural tube abnormalities,
exencephaly, and intrauterine growth retardation. In addition, we
observed abnormal p27Kip1 expression in the neural tubes of
Nup50-null animals, although no defects in p27Kip1
regulation or cell cycle control were found in Nup50-null mouse embryo
fibroblasts. These data indicate that Nup50 performs essential functions during mouse development.
 |
MATERIALS AND METHODS |
Antibodies.
The following antibodies were used in this
study: monoclonal anti-p27Kip1 (Transduction Labs,
Lexington, Ky.), anti-p21Cip1 (C-19) and anti-cyclin B1-GNS
(Santa Cruz Biotechnology, Santa Cruz, Calif.), HA.11 (anti-HA
antibody), and anti-NPC monoclonal antibody 414 (MAb414; Babco,
Berkeley, Calif.), anti-Nup153 (B. Burke, Calgary, Alberta, Canada),
anti-npap60 (N. Arnheim, Los Angeles, Calif.), horseradish peroxidase
(HRP)-conjugated anti-rabbit and anti-mouse immunoglobulin G (IgG;
Pharmacia, Kalamazoo, Mich.), fluorescein isothiocyanate (FITC)-labeled
anti-rabbit and anti-mouse IgG (Jackson Labs, West Grove, Pa.), and
anti-Ki-67 (Novocastra Laboratories). 9E10 (anti-myc tag) was prepared
by an in-house production facility.
Two-hybrid analyses and cloning of mouse Nup50.
Two-hybrid
screens were performed by using the modified two-hybrid method
developed by Hollenberg and Weintraub which has been described in
detail (35). The yeast strain L40, pBTM116 (lex fusion
vector), plex-lamin, and the 9.5/10.5-day-postcoitus (d.p.c.) mouse
embryo cDNA-VP-16 library were provided by S. Hollenberg (Portland,
Oreg.). LexA-p27Kip1 baits were constructed by subcloning
PCR-generated fragments corresponding to either full-length human
p27Kip1 or p27Kip1(72-198) into pBTM116.
Sequences were confirmed in the automated sequencing resource at The
Fred Hutchinson Cancer Research Center (FHCRC). Library plasmids from
positive yeast clones were isolated, and the specificity of two-hybrid
interactions was tested using lex-p27Kip1 and lex-lamin
baits as described elsewhere (35). Isolated clones were
sequenced using a primer derived from the VP-16 sequence, and inserts
were identified using the NCBI BLAST server.
A full-length mouse Nup50 cDNA was obtained by screening a 16-day p.c.
mouse embryo library (Novagen, Madison, Wis.) with a Nup50 probe
corresponding to residues 143 to 206. Phage DNA was purified by
standard methods, and the inserts were subcloned by recombination
according to the manufacturer's protocol (Novagen). A 1.8-kb insert
containing both the sequence corresponding to the 5' end of the rat
nap60 gene and a long poly(A) stretch was subcloned into pBluescript
(Stratagene), and a set of exonuclease III deletions was created by
standard methods and sequenced in both directions (1).
Anti-Nup50 antibody production and analyses of Nup50
expression.
Recombinant His-tagged mouse Nup50 protein was
produced by subcloning the full-length Nup50 cDNA into pET-16b
(Novagen), followed by transformation into the Escherichia
coli BL21 and purification by Ni-affinity chromatography after a
3-h induction with isopropyl-
-D-thiogalactopyranoside (IPTG) according to the manufacturer's protocol. The eluted protein was examined by gel electrophoresis and used to inoculate two rabbits
by standard methods (12). Inoculations and bleeds were performed by the FHCRC shared animal resource staff. Affinity-purified antibodies were obtained by incubating antisera with purified recombinant His-Nup50 immobilized on polyvinylidene difluoride (PVDF),
followed by elution in low-pH glycine buffer.
Protein analyses.
Cell lines used for immunostaining and
Western analyses included NIH 3T3 (obtained from C. Sherr, Memphis,
Tenn.), 293, HeLa, and U2OS (obtained from J. Roberts, FHCRC), Rat1,
and human diploid fibroblasts (obtained from C. Grandori, FHCRC). All
cells were grown in Dulbecco's modified Eagle's medium with 10%
fetal calf serum (Gibco). For Western analysis of endogenous Nup50,
cells were lysed directly on tissue culture dishes in
radioimmunoprecipitation assay (RIPA) buffer containing protease and
phosphatase inhibitors (10 mM Tris, pH 7.4; 0.15 M NaCl; 1% NP-40; 1%
deoxycholate; 0.1% sodium dodecyl sulfate [SDS]; 10 µg each of
aprotonin, leupeptin, and pepstatin per ml; 50 mM NaF; 1 mM sodium
vanadate), followed by scraping and sonication. Cell extracts were
electrophoresed on 12% polyacrylamide gels and transferred to PVDF
membranes as previously described (4). After incubation with
primary antibodies, proteins were visualized by incubation with
HRP-conjugated anti-rabbit or anti-mouse secondary antibodies as
appropriate, followed by enhanced chemiluminescence according to the
manufacturer's instructions (Pierce). Mouse tissue and embryo lysates
were prepared by sonicating freshly obtained tissues in RIPA, and 100 µg of total lysate was immunoblotted as described above.
RNA analyses.
Northern analysis of Nup50 expression in adult
mouse tissues was performed by hybridizing 10 µg of total RNA with a
full-length Nup50 probe after formaldehyde-agarose electrophoresis
(1). The tissues examined included cerebrum, cerebellum,
lungs, heart, kidney, liver, spleen, gut, pancreas, testes, ovary, and
muscle. In situ hybridization of Nup50 RNA expression in formalin-fixed paraffin sections of adult mouse testes was performed using
digoxigenin-UTP-labeled sense and antisense Nup50 probes as described
earlier (14). The specific antisense staining pattern was
confirmed with several probes derived from different regions of the
Nup50 cDNA.
Analyses of Nup50-protein interactions. (i) GST pulldown.
Glutathione S-transferase (GST)-Nup50-1 was cloned by
amplifying a region of the Nup50 cDNA from nucleotides 367 to 792, and the PCR fragment was subcloned into pUNI15 (15). pUNI15-PAF was recombined with the vector pHB2-GST with purified Cre recombinase as previously described (5), resulting in the introduction of a GST tag located 5' of the Nup50 fragment. GST-Nup50-2 was constructed by cloning the internal EcoRI/BamHI
fragment from the Nup50 cDNA into the vector pGEX-3X. Expression of
GST-Nup50-1, GST-Nup50-2, and GST alone in BL21 bacteria was induced
by the addition of 0.4 mM IPTG for 3 h at 37°C. The bacteria
were lysed by sonication in SET-Sarkosyl buffer (10 mM Tris-HCl, pH
8.0; 150 mM NaCl; 1 mM EDTA; 1.5% N-lauroylsarcosine). The
lysate was spun for 15 min at 16,000 × g. Triton X-100
was added to the supernatant to a final concentration of 2% to
sequester the Sarkosyl, and the supernatant was then bound to
GST-agarose beads (Sigma). After binding, the beads were washed four
times in SET-0.5% NP-40 buffer and stored at
20°C as a 25%
slurry in the same buffer. CS2-hp27Kip1 (24) was
transcribed and translated in vitro using the TnT Coupled Reticulocyte
Lysate System (Promega) and Tran35Slabel (ICN) according to
the manufacturer's protocol.
For each pulldown, glutathione-agarose beads containing approximately
10 µg of bound purified GST-Nup50-1, GST-Nup50-2, or
GST were used.
Nonspecific binding to the beads was first blocked
by rotating the
beads for 15 min at 4°C in GST pulldown buffer
(50 mM Tris-HCl, pH
8.0; 150 mM NaCl; 0.5% NP-40) containing 0.5
mg of bovine serum
albumin (BSA). After blocking, 2 µl of radiolabeled
p27
Kip1 in vitro translation mix was added to each
pulldown, and the
mixtures were rotated for 1 h at 4°C. The
pulldowns were then
washed four times in GST pulldown buffer. After
washing, the bound
p27
Kip1 was separated on SDS-12%
polyacrylamide
gels.
(ii) Nup50 two-hybrid screens.
To examine the two-hybrid
interactions of Nup50, the full-length Nup50 cDNA was subcloned into
pBTM116 and used to screen the following cDNA-Vp-16 libraries:
9.5/10.5 d.p.c. mouse embryo (see above), adult mouse brain (provided
by B. Howell, Bethesda, Md.), and mouse testes (provided by J. Lee,
Boulder, Colo.).
(iii) Coimmunoprecipitation.
CS2Nup50 and myc-tagged
CS2mtNup50 were constructed by cloning the Nup50 cDNA into the
cytomegalovirus-driven expression vectors pCS2 and pCS2MT, respectively
(4). For coprecipitation of Nup50 and p27, HeLa cells were
cotransfected with CS2mtNup50 and CS2p27 using the calcium phosphate
method as described earlier (4). CS2p27 has been previously
described (24). For Nup50-Nup50 and Nup50-Nup153
interactions, NIH 3T3 and 293 cells were transfected with CS2Nup50,
CS2mtNup50, and CMV-HANup153 (provided by B. Burke, Calgary, Alberta,
Canada). Cell lysates were prepared as described above in NP-40 buffer
(0.5% NP-40, 50 mM Tris; pH 8.0), and lysates were normalized for
protein concentration were incubated at 4°C for 1 h with
rotation with appropriate dilutions of primary antibodies and 30 µl
of a 1:1 slurry of phosphate-buffered saline (PBS)-protein A-Sepharose
(Sigma, St. Louis, Mo.). Precipitates were washed four times with 1 ml
of NP-40 buffer before electrophoresis and Western transfer.
Indirect immunofluorescence.
Cells were seeded into 60-mm
dishes with glass coverslips the night before staining. For
paraformaldehyde fixation, cells were fixed in 4% paraformaldehyde-PBS
for 10 min, permeabilized with 0.2% Triton-PBS, and then stained with
anti-Nup50, followed by FITC-labeled anti-rabbit IgG. The final wash
contained DAPI (4',6'-diamidino-2-phenylindole) to visualize cell
nuclei. For methanol-acetone fixation, coverslips were fixed in
methanol for 30 min at
20°C and then quickly rinsed in acetone at
4°C as described earlier (6). After the acetone rinse, the
coverslips were washed for 5 min in 1× PBS and then treated as
described above. To examine the immunolocalization of Nup153 and other
NPC proteins, cells were stained with either MAb414, which recognizes
multiple NPC proteins, or anti-Nup153, followed by FITC-labeled
anti-rabbit or anti-mouse IgG. For costaining of cells with anti-Nup50
and MAb414, both antibodies were used together, followed by staining with a mixture of anti-rabbit and anti-mouse secondary antibodies. Coverslips were examined using either a Nikon E800 or a Deltavision wide-field deconvolution microscope as indicated.
For differential permeabilization of the nuclear envelope and plasma
membrane, MEFs growing on coverslips were rinsed in transport
buffer
(20 mM HEPES, pH 7.3; 110 mM potassium acetate; 5 mM sodium
acetate; 2 mM magnesium acetate; 2 mM dithiothreitol, 0.5 mM EGTA)
for 5 min at
4°C. The cells were then treated for 5 min at 4°C
with digitonin at
a concentration of 0, 2, 5, 10, 15, or 30 µg/ml
in transport buffer
in order to find a concentration range at
which the cell membrane but
not the nuclear envelope was permeabilized.
As a control, one coverslip
was treated with 0.5% Triton X-100
in transport buffer. After
digitonin treatment, the coverslips
were washed for 15 min at 4°C.
The cells were then incubated in
primary antibody (Babco MAb414 diluted
1:500 in transport buffer
or anti-Nup50 polyclonal diluted at 1:1,000
in transport buffer)
for 30 min, followed by three rinses in transport
buffer. After
rinsing, the cells were incubated in secondary antibody
(anti-mouse
or anti-rabbit antibody, respectively, labeled with FITC,
both
from Jackson Laboratories) at a dilution of 1:150 in transport
buffer. Finally, the coverslips were washed three times in transport
buffer and
mounted.
Genomic cloning and targeted disruption of the mouse Nup50
gene.
An approximately 40-kb genomic DNA fragment containing the
mouse Nup50 gene was obtained from a mouse 129/Sv genomic library (provided by P. Soriano, Seattle, Wash.) using a 268-bp
EcoRI-HincII fragment from the 5' end of the
Nup50 cDNA as a probe. Restriction maps, intron-exon boundaries, and
exonic sequences were determined by Southern blot analysis and
sequencing with primers derived from the Nup50 cDNA sequence. A
knockout vector was constructed by cloning a 6.5-kb SnaBI
fragment encompassing sequences upstream of exon 1 and most of the
3.0-kb intron 1, as the upstream long arm, and a 2-kb
NsiI-SacI fragment including portions of intron 4 and exon 5 as the downstream short arm into the targeting vector pSA
Geolox2dta (provided by P. Soriano, FHCRC). This vector contains a splice acceptor site upstream and stop codons in all three reading frames downstream of the
geo sequences, as well as the diphtheria toxin A gene for negative selection against random integrants. The
vector was linearized with XhoI and electroporated into XY AK7 ES cells. ES colonies were selected in 300 µg of G418 per ml and
correctly targeted clones were identified by PCR utilizing primers
derived from the
geo and Nup50 genomic
(5'-TTCGCAGCGCATCGCCTTCT-3' and
5'-GGGCAGCATCTTTACCAAAC-3'). Clones identified as
homologous recombinants were confirmed by Southern analysis using
probes that spanned both the 5' and 3' recombination junctions. ES
cells were introduced into 3.5-d.p.c. C57/B6J embryos to generate
chimeric mice, and germ line transmission was achieved by mating
chimeric males to wild-type females.
Analysis of Nup50-null embryos and embryonic fibroblasts.
For analysis of
-galactosidase activity, embryos were fixed and
stained with X-Gal
(5-bromo-4-chloro-3-indolyl-
-D-galactopyranoside) as
described earlier (7). For histological analyses, embryos were fixed in 4% paraformaldehyde-PBS, dehydrated in ethanol, and
embedded in paraffin. For immunostaining of Nup50 and
p27Kip1, paraffin-embedded sections were dewaxed in xylenes
and rehydrated in an ethanol series, followed by blocking endogenous
peroxidases with 1% hydrogen peroxide in 1× PBS for 15 min. After
washing in 1× PBS, the sections for p27Kip1 staining (but
not the sections for Nup50 staining) underwent antigen retrieval by
boiling in 10 mM citric acid (pH 6.0) for 10 min in a microwave oven.
After cooling, both p27Kip1 and Nup50 sections were
processed identically by rinsing in PBS and then blocking for 30 min in
4% BSA-1× PBS containing 2% normal horse serum (Vector Labs). The
sections were then incubated for 1 h in anti-Nup50 polyclonal
antibody diluted 1:1,000 in 4% BSA-1× PBS or in
anti-p27Kip1 monoclonal antibody diluted 1:500 in 4%
BSA-1× PBS. Following three rinses in PBS, the slides were treated
for 30 min with biotinylated universal secondary antibody from the ABC
Elite kit (Vector Labs), diluted 1:500 in 4% BSA-1× PBS-2% horse
serum. Next, the slides were again rinsed in PBS and then incubated for
30 min in ABC reagent, diluted in 4% BSA-1× PBS as described in the
ABC Elite kit. Finally, the sections were again rinsed in PBS and
developed using the DAB substrate kit (Vector Labs) for approximately 5 min or until adequate signal was seen. Slides were then washed, dehydrated in an ethanol series and xylenes, air dried, and mounted in
Permount medium (Fisher Scientific).
MEFs were prepared from 12- to 14-p.c. embryos as described elsewhere
(
13). MEF genotypes were determined by PCR using primers
specific to both the mutant and wild-type Nup50 alleles and were
confirmed by quantitative

-galactosidase assays and Nup50
immunostaining.
Cell cycle analyses were performed as described earlier
(
24).
For density and serum arrests, cells were either grown
to saturation
density or placed in DME with 0.5% serum for 72 h
prior to release
them from growth arrest. Leptomycin B was a gift of M. Yoshida
(Tokyo, Japan) and used at a final concentration of 10 ng/ml.
 |
RESULTS |
Two-hybrid analyses of p27Kip1-interacting proteins and
cloning of mouse Nup50.
We used a two-hybrid approach to identify
proteins that interact with p27Kip1. A full-length human
p27Kip1 cDNA was used as bait in several independent
screens of a 9.5/10.5 d.p.c. mouse embryo library. The vast majority of
the true-positive clones identified in these screens represented known
cyclins, predominantly cyclins D1 and D2, although cyclins A, B, E, and I were also identified. In addition, several independent overlapping clones of a noncyclin cDNA were identified. This sequence corresponded to the murine homologue of a rat nuclear-pore-associated protein originally termed npap60 and now renamed Nup50 (10). In
order to increase the detection of noncyclin p27Kip1
interactors, we used an N-terminally truncated p27Kip1
construct, lex-p27Kip1(72-198), that eliminates the
cyclin-CDK interaction domain. As expected, no cyclin cDNAs were
detected in positive clones when this bait was used to screen the mouse
embryo library. Remarkably, however, 100% of the multiple, independent
positive clones identified with the p27Kip1(72-198) bait
represented the mouse Nup50 cDNA. We have used GST-pulldown and
coimmunoprecipitation approaches to independently assess the interaction of p27Kip1 and Nup50 in a system other than a
two-hybrid screen. We constructed two GST-Nup50 fusion proteins
containing the minimal region of Nup50 isolated in the two-hybrid
clones that could mediate interaction with p27Kip1. The
GST-Nup50 fragments, but not GST alone, bound to p27Kip1
protein that was translated in vitro or endogenous p27Kip1
contained within cell lysates (Fig. 1A
and data not shown). We also transfected HeLa cells with expression
vectors for Nup50 and p27Kip1 and observed specific
coimmunoprecipitation of Nup50 and p27Kip1, although the
fraction of p27Kip1 bound to Nup50 was relatively small
(Fig. 1B and see below). However, since living cells and reticulocyte
lysates contain many nucleoporins and transport receptors, the observed
interactions between p27Kip1 and Nup50 in the two-hybrid,
GST-pulldown, and coimmunoprecipitation assays may be either direct or
indirect and bridged via other proteins.

View larger version (55K):
[in this window]
[in a new window]
|
FIG. 1.
Nup50 is a p27Kip1-interacting protein. (A)
GST pulldown assay. p27Kip1 translated in vitro bound
specifically to two overlapping GST-Nup50 fusion proteins containing
the minimal p27Kip1 interaction domain of Nup50 (lanes 3 and 4) but not to GST alone (lane 2) (B) Coimmunoprecipitation of Nup50
and p27Kip1. HeLa cells were transfected with expression
vectors for p27 (lanes 1 and 3) and myc-tagged Nup50 (lanes 2 and 3).
Lysates either were Western blotted with anti-Nup50 or
anti-p27Kip1 antisera or were immunoprecipitated with
anti-myc tag antibody followed by Western blotting with
anti-p27Kip1 as indicated. A portion (10%) of the total
amount of immunoprecipitated lysate was used in the Western blots. (C)
Sequence of the mouse Nup50 gene. The minimal region found in
two-hybrid screens to interact with p27Kip1 (boldface) and
putative Ran-binding domain (underlined) are indicated. (D) Alignment
of the C terminus of Nup50 with the Ran-binding domain of Ran-binding
protein 2. (E) Alignment of mouse Nup50 with n50rel. The minimal
p27Kip1 interaction domain is shown in boldface.
|
|
We cloned and sequenced a 1.8-kb Nup50 cDNA obtained by screening a
16-day-old mouse embryo library with a mouse Nup50 probe
derived from
the longest two-hybrid clone. The Nup50 open reading
frame encodes a
466-amino-acid protein with a predicted molecular
mass of 50,000 Da
(Fig.
1C, GenBank accession number
AF229256).
The predicted protein is
94% identical to the 467-amino-acid rat
Nup50 protein and 77%
identical to the 468-amino-acid human Nup50
sequence (a corrected rat
Nup50 sequence, accession number
U41845,
has recently been entered in
GenBank in which a frameshift in
the C terminus has been corrected).
The minimal mouse Nup50 cDNA
fragment that was isolated in the
p27
Kip1 two-hybrid screen is indicated. The C terminus of
mouse Nup50
contains a domain with homology to the Ran-binding domains
of
RanBP1 and RanBP2 that is also present in both the human and the
rat
Nup50 sequences (Fig.
1C and D and data not
shown).
The lex-p27
Kip1(72-198) bait was also used to screen a
testis-specific two-hybrid library. In this screen, approximately 10%
of
the multiple independent clones identified represented Nup50,
whereas all of the remaining clones represented a Nup50-related
cDNA
that we have designated n50rel because of its sequence homology
to
Nup50. A partial sequence of n50rel was obtained by assembling
the
overlapping independent clones obtained in the testis two-hybrid
screen
and revealed that n50rel and Nup50 are highly related in
the minimal
p27
Kip1-interaction region (69% identical over 64 amino
acids) but diverge
in the remaining regions sequenced (Fig.
1E).
Mouse Nup50 is a nuclear-pore-associated protein that is widely
expressed.
Northern blot analysis of total RNA from normal mouse
tissues detected low levels of Nup50 mRNA in most tissues, and 10- to 20-fold more mRNA in testes than other tissues (not shown). In situ
hybridization of sectioned testes demonstrated intense expression of
Nup50 mRNA in a specific zone of spermatocytes undergoing, or that had
recently completed, meiosis (Fig. 2A).
This is consistent with the reported observation that rat Nup50 protein
is highly expressed in the testes and undergoes changes in expression
and localization during germ cell differentiation. In contrast to Nup50, Northern analysis of n50rel mRNA revealed high expression in
adult testis but no expression in other tissues (not shown). Moreover, whereas the DBEST database contains many Nup50
expressed sequence tags (ESTs) derived from libraries
representing a wide variety of human, murine, and rat tissues, the only
EST corresponding to n50rel found in BLAST searches was isolated from a
mouse testis library (accession number AA183570T). Finally, although we
isolated Nup50 cDNAs from both total-embryo and testis two-hybrid
libraries, n50rel cDNAs were only isolated from the testis library.
These data suggest that, whereas Nup50 is widely expressed, n50rel
expression is restricted to the testes. It is important to note,
however, that we currently have no data indicating that n50rel encodes an expressed nucleoporin.

View larger version (50K):
[in this window]
[in a new window]
|
FIG. 2.
Nup50 is a widely expressed nucleoporin. (A) In situ
hybridization pattern of Nup50 mRNA in adult mouse testis. (B) Western
analysis of proteins detected by anti-Nup50 antibody in either
mock-transfected NIH 3T3 cells (lane 1) or NIH 3T3 cells transfected
with myc-epitope tagged Nup50 (lane 2). (C) Western analysis of Nup50
expression in adult mouse tissues using affinity-purified anti-Nup50
antibody. (D) Mouse Nup50 localizes to the nuclear pore complex. (Left
and center) Deltavision photomicrographs of MEFs fixed with
methanol-acetone and stained with anti-Nup50 antibody. Panels: left,
staining pattern of Nup50 in surface and equatorial planes; center,
colocalization of Nup50 (green) with nucleoporins detected by MAb414
(red); right, Nup50 immunostaining reveals a homogeneous nuclear
pattern in MEFs fixed with paraformaldehyde.
|
|
We have made rabbit polyclonal antibodies to full-length His-tagged
mouse Nup50 protein expressed and purified in
E. coli.
Both
of these antisera recognize a single band of approximately
60,000 Da in
NIH 3T3 cells and correctly recognize transfected
myc epitope-tagged
Nup50 (Fig.
2B and data not shown). Surveys
of mouse tissues revealed
that Nup50 is detected in all tissues
with various abundance, with the
highest expression in the testes
(Fig.
2C and data not shown). Some
smaller products were also
observed in some tissues, which could
represent either degradation
or in vivo processing. These species were
also found in cells
transfected with Nup50 expression vectors; thus,
they are probably
not due to alternate splicing (not shown).
Furthermore, freeze-thawing
of tissue extracts caused the conversion of
full-length Nup50
to low-molecular-weight forms, suggesting that they
represent
proteolytic products (not shown). It is unlikely that these
bands
represent other proteins immunologically related to Nup50 that
are detected by the anti-Nup50 antibodies, since these antisera
do not
reveal any proteins in lysate prepared from Nup50-null
embryos (see
Fig.
4D).
We have observed that mouse Nup50 immunostaining reveals a classic NPC
pattern and colocalizes with other NPC proteins in
primary mouse and
human fibroblasts, as well as in 3T3, 293, HeLa,
U2OS, and rat1 cells
(Fig.
2D and data not shown). By using digitonin
permeabilization
conditions that preferentially solubilize the
plasma membrane but not
the nuclear envelope, we observed that
Nup50 is found at the
nucleoplasmic side of the nuclear envelope
(data not shown). The
subcellular localization of Nup50 in all
of the cultured cells we
examined was strongly dependent upon
fixation technique.
Methanol-acetone fixation yielded exclusively
nuclear envelope
staining, whereas paraformaldehyde fixation resulted
in very bright
homogeneous nuclear staining except in nucleolar
regions (Fig.
2D).
Guan et al. have found a similar pattern of
fixation-dependent Nup50
staining in NRK cells (
10). These data
suggest that a
nuclear pool of Nup50 that is not associated with
the nuclear envelope
is either extracted or epitope masked by
methanol-acetone fixation.
Similarly, Fan et al. found that rat
Nup50 stained in a homogeneous
nuclear pattern during specific
stages of spermatocyte differentiation,
demonstrating that rat
Nup50 may also localize to regions of the
nucleus other than the
nuclear envelope (
6).
Interactions of Nup50 with NPC proteins.
We used the
full-length Nup50 cDNA as bait in two-hybrid analyses to determine if
Nup50 interacts with other components of the NPC. In independent
screens of mouse embryo, brain, and testis libraries, we have found the
following NPC proteins that displayed specific two-hybrid interactions
with Nup50: importin
2, importin
, transportin, Nup153, Ran
binding protein 7, and Nup50 itself. This analysis confirms the
association of Nup50 with the NPC observed by immunostaining. Most of
these proteins are shuttling import receptor proteins involved in the
nucleocytoplasmic transport of various cargo. The Nup153 protein is
found in the basket region of the nuclear side of the NPC and plays key
roles in both the import and the export of proteins and mRNA (2,
17, 29, 33). In addition to the two-hybrid interactions, we have
also coimmunoprecipitated Nup50-Nup153 complexes and Nup50-Nup50
complexes from transfected cells, confirming that these proteins can be found in complexes in mammalian cells in vivo (Fig.
3). Furthermore, Guan et al. have used
immunogold electron microscopy and colocalized Nup153 and Nup50 to very
similar nucleoplasmic regions of the NPC (10). Finally, the
endogenous Nup153 and Nup50 proteins can be coimmunoprecipitated from
rat liver nuclei (T. Guan and L. Gerace, personal communication). In
sum, these data support the notion that Nup50 and Nup153 are found in
complexes in vivo, although it is possible that the Nup50-Nup153
interaction is indirect and mediated by other proteins in both the
two-hybrid and coprecipitation experiments.

View larger version (26K):
[in this window]
[in a new window]
|
FIG. 3.
(A) Coimmunoprecipitation of Nup50 with Nup153. 293 cells were transfected with vectors expressing HANup153 HANup153-Nup50
as indicated. Lysates were immunoprecipitated (IP) with anti-Nup50
antibody as indicated and Western blotted with antihemagglutinin (HA)
tag antibody. Nup153 is precipitated by anti-Nup50 only when Nup50 is
cotransfected. A total of 10% of the amount of lysate
immunoprecipitated was run in the lane labeled lysate. (B) Nup50 forms
complexes with itself. NIH 3T3 cells were transfected with either a
myc-tagged Nup50 expression vector (lanes 2 and 4) or control vector
(lanes 1 and 3). The endogenous Nup50 is precipitated by the anti-myc
tag antibody only when mt-Nup50 is coexpressed.
|
|
Genomic cloning and targeted deletion of Nup50.
We made a
targeted deletion of Nup50 in the mouse germ line to study its
function. A mouse Nup50 genomic clone was obtained by screening a mouse
genomic library, and the intron-exon structure map was determined using
primers derived from the mouse Nup50 cDNA. We have found that there are
at least seven exons in the mouse Nup50 gene and that the first exon is
noncoding (Fig. 4A and data not shown).
This genomic structure is quite similar to that of the human Nup50
locus (31). We constructed a targeting vector using
pSA
Geolox2dta, which contains a splice acceptor upstream of the
-geo selectable marker and the diphtheria toxin A gene to select
against random integrations (Fig. 4A) (7). Homologous
recombination of this vector with the endogenous Nup50 gene results in
a transcript expressed from the endogenous Nup50 transcription unit in
which Nup50 exon 1 is spliced to the
-geo cassette, which contains
stop codons in all three reading frames following the selectable marker
sequences and which terminates translation. This strategy also allows
the determination of the endogenous Nup50 mRNA expression pattern by
analysis of
-galactosidase activity. Mouse ES cells were
electroporated with the targeting vector, and homologous recombinants
were identified by standard PCR-based techniques and confirmed by
Southern blotting (Fig. 4B and C and data not shown). ES cells were
microinjected into C57/B6J blastocysts and backcrossed into C57/B6J
females after germ line transmission of the mutant allele was
confirmed.

View larger version (38K):
[in this window]
[in a new window]
|
FIG. 4.
Genomic cloning and targeted disruption of mouse Nup50.
(A) Genomic structure of the mouse Nup50 locus and construction of a
splice acceptor targeting vector. Introns were not completely sequenced
and are not drawn to scale. In the correctly targeted locus, the
selectable marker is expressed from the endogenous Nup50 transcription
unit. (B) PCR analysis of ES cell controls (ES-1 and ES-2) and clones
with targeted Nup50 alleles. Only clones with targeted alleles yield a
diagnostic PCR product. (C) Southern analysis of the 3' end of targeted
Nup50 alleles. Note that all PCR-positive clones shown in panel B
except 13-10 had the expected genomic structure. The structure of the
5' end of the recombined locus in the targeted clones was also
confirmed by Southern analysis (not shown). (D) The targeted Nup50
allele is a null mutation. Total embryo lysate was prepared from E12
embryos from a Nup50+/ cross. The genotypes of the
embryos are indicated. Note that no Nup50 protein is detected by
anti-Nup50 in the Nup50 / embryo lysate, whereas control
proteins such as Cdk2 are easily detected.
|
|
F
1 mice heterozygous for the mutant Nup50 allele were mated
to assess the consequence of a homozygous-null Nup50 mutation.
No live
Nup50
/
mice were obtained out of more than 200 pups
genotyped from the
crosses, although Nup50
+/+ and
Nup50
+/
animals were found at the expected frequency
(data not shown).
Thus, homozygous deletion of Nup50 appeared to cause
embryonic
lethality. Heterozygosity for Nup50 was not associated with
any
detectable abnormalities in either male or female animals monitored
for more than 2
years.
Embryonic lethality due to deletion of Nup50 is associated with
neural tube defects, exencephaly, and intrauterine growth
retardation.
We next analyzed embryos from timed F1
matings at various embryonic stages. In contrast to the live births
described above, this analysis revealed homozygous Nup50-null embryos
at the expected frequency (Table 1).
Embryo genotype was assessed in three ways: (i) PCR, (ii)
-galactosidase expression, and (iii) immunostaining-Western blotting. In wild-type embryos Nup50 expression was easily detected at
all developmental stages tested (data not shown). In contrast, no Nup50
expression was detected in homozygous-null animals by either
immunostaining embryo sections (not shown) or Western analysis of total
embryo lysate (Fig. 4D), thus confirming that the targeting vector
produced a true null allele.
We found that homozygous Nup50 deletion was associated with a grossly
abnormal phenotype beginning at approximately embryonic
day 8.5 (E8.5).
The earliest detectable abnormality in the Nup50-null
animals is a
kinked neural tube around E8.5 (Fig.
5).
Moreover,
the neural tube displays the strongest

-galactosidase
activity
at this developmental stage, indicating that the Nup50 gene is
highly expressed in the developing neural tube. Longer

-galactosidase
assays revealed Nup50 expression in all embryonic
tissues, a finding
consistent with the ubiquitous expression in adult
tissues as
previously observed (Fig.
5). Later in development, the
neural
tube defect in mutant animals becomes quite prominent and is
characterized
by a failure of cranial neural tube closure and
ultimately by
exencephaly (Fig.
5 and data not shown). The Nup50-null
animals
also displayed significantly reduced size compared with normal
and heterozygous littermates (Fig.
5). Live Nup50-null animals
were
found as late as day E19.5; thus, embryonic death likely
occurs late in
gestation or perinatally.

View larger version (54K):
[in this window]
[in a new window]
|
FIG. 5.
Morphologic abnormalities in Nup50-null mouse embryos.
Embryos were dissected from pregnant Nup50+/ females
after timed matings, and the Nup50 genotypes are indicated. The E8.5,
E10.5, and E13.5 embryos were stained for -galactosidase activity
which reveals the endogenous Nup50 expression pattern. The E19.5
embryos were fixed in paraformaldehyde and stored in 70% ethanol prior
to photography.
|
|
Analysis of p27Kip1 expression in Nup50-null
animals.
We examined p27Kip1 expression in normal and
Nup50-null animals. In normal embryos, p27Kip1 expression
was found in many tissues, but it was most highly expressed throughout
the central nervous system (Fig. 6 and
data not shown). The developing neural tube displayed a clear gradient of p27Kip1 staining, such that p27Kip1
expression was highest in the germinal zone of the neuroepithelium (postmitotic cells) and lowest in the proliferating marginal zone. This
inverse relationship between p27Kip1 expression and
neuroepithelial cell proliferation is illustrated by the inverse
staining pattern of p27Kip1 and the proliferative marker
Ki-67 (Fig. 6). In Nup50-null animals this gradient is lost in many
regions of the central nervous system (CNS), and neuroepithelial cells
expressing high levels of p27Kip1 were found scattered
throughout the abnormally developing neural tube. Additionally, the
gradient of Ki-67 staining was lost in regions of the neural tube in
Nup50-null embryos such that no marginal zone was easily demarcated,
suggesting that the Nup50 deletion is associated with a neural tube
proliferative defect.

View larger version (105K):
[in this window]
[in a new window]
|
FIG. 6.
Transverse sections of E10.5 Nup50+/+ (left)
and Nup50 / (right) embryos were immunostained with
either anti-Ki-67 antibody or anti-p27Kip1 antibody as
indicated. Approximately equivalent sections from a region just caudal
to the open portion of the Nup50 / neural tube are
shown. Note the low Ki-67 and high p27Kip1 expression in
the marginal zone (MZ) compared to the germinal zone (GZ) of the neural
tube in the wild-type embryo and the loss of this relationship in the
Nup50-null embryo. The bottom image in each column is a
higher-magnification image of the neural tube that clearly reveals the
p27Kip1 gradient in the normal neuroepithelium.
|
|
Analysis of Nup50-null fibroblasts.
We prepared MEFs from 12- to 14-d.p.c. No expression of Nup50 was detected in Nup50-null cells
(Fig. 7A). In contrast, the highly
related p70 protein detected by the anti-Nup50 antibody previously
designated anti-npap60 (6, 10) is expressed equally in all
MEFs, regardless of their Nup50 genotype (Fig. 7A). We found that
Nup50
/
, Nup50+/
, and Nup50+/+
MEFs proliferated at similar rates; that asynchronous cultures of
wild-type and Nup50-null cells had indistinguishable cell cycle profiles; and that Nup50-null and wild-type cells exited and re-entered the cell cycle following serum starvation and density arrest with similar kinetics (data not shown). We also examined the localization and abundance of endogenous p27Kip1 and found no
differences resulting from Nup50 deletion (Fig. 7B and data not shown).
Thus, we have observed no defects in either p27Kip1
regulation or cell cycle control in Nup50-null MEFs.

View larger version (56K):
[in this window]
[in a new window]
|
FIG. 7.
Analyses of Nup50 / MEFs. (A) The
Nup50-related protein p70 is expressed in Nup50-null MEFs. Lysates
prepared from MEFs with the indicated genotypes were electrophoresed,
and the same filter was cut in half and probed with either the
anti-npap60 antibody developed by Fan et al. (6) or
anti-Nup50. Note that both antisera detect Nup50 but only the
anti-npap60 detects p70. No Nup50 expression is detected by either
antibody in Nup50-null cells, whereas p70 expression is unaffected by
the Nup50 deletion. (B) Endogenous p27Kip1 is expressed at
similar levels in wild-type and Nup50-null cells. (C) Transfected
proteins correctly localize to the nucleus in Nup50-null MEFs. Staining
patterns of p27Kip1 and cyclin E with corresponding DAPI
images (to reveal all nuclei) are shown in the top and middle panels,
respectively. The bottom panel depicts a -galactosidase assay of
cells transfected with either a NLS- -galactosidase or a
-galactosidase expression vector. NLS- -galactosidase contains
the simian virus 40 NLS. (D) No Nup50 staining is detected in
Nup50-null cells fixed with either paraformaldehyde (PFA [top panel])
or methanol-acetone (middle panel). Corresponding DAPI images are also
shown. Nup153 and NPC proteins detected by MAb414 correctly localize to
the NPC in Nup50-null cells (bottom panel).
|
|
We examined the localization of several endogenous and transfected
proteins in MEFs and found that c-myc, p21
Cip1,
p27
Kip1, cyclin E, and NLS-

-galactosidase were all
correctly localized
to the cell nucleus in Nup50-null cells (Fig.
7C
and data not
shown). Thus, protein import appears grossly normal in
Nup50-null
cells, although there could be subtle differences in protein
import
rates between normal and mutant cells that might not be
reflected
by protein localization at steady state. We also examined the
localization of endogenous and transfected cyclin B1, which is
dependent upon the function of the Crm1 export receptor. We found
identical cyclin B1 staining in wild-type and mutant MEFs in the
absence or presence of leptomycin B, suggesting that Crm1-dependent
protein export is also grossly normal in Nup50-null fibroblasts
(data
not shown). Finally, we characterized NPC proteins in MEFs.
We found
that no Nup50 expression was detected by immunocytochemistry
in
Nup50-null cells fixed with either paraformaldehyde or methanol-acetone
and that the expression and localization of Nup153 as well as
NPC
proteins detected by MAb414 were normal in Nup50-null cells
(Fig.
7D).
Thus, Nup50 expression is not required for the localization
of Nup153
and other nucleoporins to the NPC in
MEFs.
 |
DISCUSSION |
We have found that murine Nup50 localizes to the NPC and displays
specific two-hybrid interactions with several well-defined constituents of the nucleocytoplasmic transport machinery, as well as the p27Kip1 protein. Most of the Nup50 two-hybrid
interactors that we identified are mobile import receptors that carry
various classes of protein cargo into the nucleus (importin
,
importin
, transportin, and RanBP7). We also found two-hybrid
interactions between Nup50 and itself and with the Nup153 protein.
Unlike the importin superfamily, Nup153 is an integral component of the
NPC involved in multiple transport processes that physically interacts
with several transport receptors (including importin
, importin
,
exportin, and transportin), the NPC, and Ran. We have also found that
Nup50 can form complexes (although not necessarily via direct
interaction) with p27Kip1 and Nup153 in GST pulldown and
coimmunoprecipitation assays. In agreement with our observations, Guan
et al. found that the endogenous Nup50 and Nup153 proteins colocalize
to a similar region of the nucleoplasmic side of the NPC and can be
coimmunoprecipitated from rat liver nuclei (10; Guan
and Gerace, personal communication).
The targeted disruption of Nup50 caused complex neural tube and CNS
abnormalities and growth retardation. Although we have found that Nup50
is expressed ubiquitously in adult and embryonic tissues, the
phenotypic abnormalities associated with the Nup50 deletion were most
severe in the CNS. This finding is in contrast with the only other
reported deletion of a nucleoporin in mice, the CAN-Nup214 protein.
CAN-Nup214-null cells are not viable, and its deletion causes early
embryonic death as maternal stores of CAN-Nup214 mRNA are depleted
(34). Most embryonic tissues in Nup50-null animals appear
grossly normal. However, the intrauterine growth retardation observed
in Nup50-null embryos suggests that Nup50-null tissues other than the
CNS are affected, and it is possible that embryonic tissues that appear
normal may have more subtle defects resulting from Nup50 loss.
We have not yet found any defects in Nup50-null MEFs. Thus, either the
function performed by Nup50 is not required in MEFs or other NPC
proteins may be functionally redundant with Nup50 and compensate for
its absence. Guan et al. have inhibited Nup50 function in NRK cells by
microinjecting anti-Nup50 antibodies and found that Nup50 inhibition
specifically blocks the nuclear export of proteins with leucine-rich
Crm1-dependent NES (10). Crm1-dependent export appears to be
an essential cellular function: inhibition of Crm1 with the drug
leptomycin B in mammalian cells causes cell death, and Crm1 is an
essential gene in Saccharomyces cerevisiae (28).
Thus, our finding that Nup50-null MEFs proliferate and regulate cyclin
B1 localization normally supports the idea that Nup50 is functionally
redundant with other NPC proteins in some cell types. Our observation
that p70, a protein highly related to Nup50, is expressed equally in
wild-type and Nup50-null MEFs raises the possibility that p70
compensates for Nup50 in Nup50-null MEFs. Perhaps other structural
and/or functional homologues will be found in other tissues. We have
identified n50rel as a putative Nup50 homologue expressed in the
testis. In humans, Nup50 homologous sequences have been detected by
hybridization on chromosomes 5, 6, and 14, in addition to the bona fide
Nup50 gene on 22q13.3, although it is not known if these loci represent
functional genes (31).
We have observed variation in Nup50 abundance, despite its ubiquitous
expression, most notably as increased expression in the adult testes
and in the embryonic neural tube. This expression pattern in the
developing neural tube is consistent with the essential role for Nup50
in neurulation demonstrated by the Nup50-null phenotype. Neural tube
morphogenesis is extremely complex, and a large number of gene products
have been identified that are required for this process
(23). Thus, the mechanisms through which Nup50 deletion leads to the observed phenotypic abnormalities remains unknown.
We initially identified Nup50 through its two-hybrid interaction with
p27Kip1. p27Kip1 export has been reported to be
leptomycin B sensitive (30), and the findings of Guan et al.
implicating Nup50 in the Crm1 pathway export (10) led us to
hypothesize that Nup50 might mediate interactions between
p27Kip1 and its export pathway. We have not, however,
identified any specific abnormalities in p27Kip1 regulation
directly attributable to Nup50 deletion. Nup50-null MEFs exhibited no
obvious defects in either p27Kip1 regulation and/or cell
cycle control. One possibility is that another protein, such as p70,
compensates for the absence of Nup50. Alternatively, Nup50 may not play
any direct role in p27Kip1 regulation. To further address
this question, we have examined p27Kip1 expression in the
most abnormal tissue in Nup50-null animals, the developing neural tube.
We found that p27Kip1 expression is highly regulated in the
developing neuroepithelium and correlates strongly with proliferative
status. In Nup50-null embryos this correlation breaks down, and cells
highly expressing p27Kip1 were found throughout the
neuroepithelium. Abnormal neuroepithelial cell proliferation has been
associated with neural tube defects, and it is tempting to speculate
that the abnormalities observed in the Nup50-null animals are at least
partially attributable to aberrant p27Kip1 regulation
(27). However, because the neural tube becomes disordered in
Nup50 mutant animals, it is difficult to determine if the alterations in p27Kip1 expression in Nup50-null animals are the cause
or the consequence of the neural tube abnormalities. A mechanistic
understanding of these abnormalities thus must await a clearer
understanding of Nup50 function in nucleocytoplasmic transport.
 |
ACKNOWLEDGMENTS |
We thank Mark Groudine and Jim Roberts for their advice, support,
and critical review of the manuscript. We also thank Larry Gerace,
Norman Arnheim, and Martin Eilers for communicating data prior to
publication and Brian Burke for providing reagents.
B.E.C. is a W. M. Keck Distinguished Young Scholar in Medical
Research and a James S. McDonnell Scholar. This work was supported by
NIH grants R01 CA 84069 (B.E.C.) and RO1 DK52530 (R.K.).
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Fred Hutchinson
Cancer Research Center, 1100 Fairview Ave., N Mailstop D1-100, Seattle, WA 98109. Phone: (206) 667-4524. Fax: (206) 667-6124. E-mail: bclurman{at}fhcrc.org.
 |
REFERENCES |
| 1.
|
Ausubel, F.,
R. Brent,
R. Kingston,
D. Moore,
J. Seidman,
J. Smith, and K. Struhl.
1995.
Current protocols in molecular biology.
John Wiley & Sons, New York, N.Y.
|
| 2.
|
Bastos, R.,
A. Lin,
M. Enarson, and B. Burke.
1996.
Targeting and function in mRNA export of nuclear pore complex protein Nup153.
J. Cell Biol.
134:1141-1156[Abstract/Free Full Text].
|
| 3.
|
Clurman, B. E., and P. Porter.
1998.
New insights into the tumor suppression function of P27(kip1).
Proc. Natl. Acad. Sci. USA
95:15158-15160[Free Full Text].
|
| 4.
|
Clurman, B. E.,
R. J. Sheaff,
K. Thress,
M. Groudine, and J. M. Roberts.
1996.
Turnover of cyclin E by the ubiquitin-proteasome pathway is regulated by Cdk2 binding and cyclin phosphorylation.
Genes Dev.
10:1979-1990[Abstract/Free Full Text].
|
| 5.
|
Doye, V., and E. Hurt.
1997.
From nucleoporins to nuclear pore complexes.
Curr. Opin. Cell Biol.
9:401-411[CrossRef][Medline].
|
| 6.
|
Fan, F.,
C. P. Liu,
O. Korobova,
C. Heyting,
H. H. Offenberg,
G. Trump, and N. Arnheim.
1997.
cDNA cloning and characterization of Npap60: a novel rat nuclear pore-associated protein with an unusual subcellular localization during male germ cell differentiation.
Genomics
40:444-453[CrossRef][Medline].
|
| 7.
|
Friedrich, G., and P. Soriano.
1991.
Promoter traps in embryonic stem cells: a genetic screen to identify and mutate developmental genes in mice.
Genes Dev.
5:1513-1523[Abstract/Free Full Text].
|
| 8.
|
Goldberg, M. W., and T. D. Allen.
1996.
The nuclear pore complex and lamina: three-dimensional structures and interactions determined by field emission in-lens scanning electron microscopy.
J. Mol. Biol.
257:848-865[CrossRef][Medline].
|
| 9.
|
Gorlich, D.
1998.
Transport into and out of the cell nucleus.
EMBO J.
17:2721-2727[CrossRef][Medline].
|
| 10.
|
Guan, T.,
R. Kehlenbach,
E. Schirmer,
A. Kehlenbach,
F. Fan,
B. E. Clurman,
N. Arnheim, and L. Gerace.
2000.
Nup50, a nucleoplasmically oriented nucleoporin with a role in nuclear protein export.
Mol. Cell. Biol.
20:5619-5630[Abstract/Free Full Text].
|
| 11.
|
Hagting, A.,
M. Jackman,
K. Simpson, and J. Pines.
1999.
Translocation of cyclin B1 to the nucleus at prophase requires a phosphorylation-dependent nuclear import signal.
Curr. Biol.
9:680-689[CrossRef][Medline].
|
| 12.
|
Harlow, E., and D. Lane.
1999.
Using antibodies: a laboratory manual.
Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
|
| 13.
|
Hogan, B.,
V. Beddington,
F. Costantini, and E. Lacey.
1994.
Manipulating the mouse embryo: a laboratory manual, 2nd ed.
Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
|
| 14.
|
Kopan, R., and H. Weintraub.
1993.
Mouse notch: expression in hair follicles correlates with cell fate determination.
J. Cell Biol.
121:631-641[Abstract/Free Full Text].
|
| 15.
|
Liu, Q.,
M. Z. Li,
D. Leibham,
D. Cortez, and S. J. Elledge.
1998.
The univector plasmid-fusion system, a method for rapid construction of recombinant DNA without restriction enzymes.
Curr. Biol.
8:1300-1309[CrossRef][Medline].
|
| 16.
|
Melchior, F., and L. Gerace.
1995.
Mechanisms of nuclear protein import.
Curr. Opin. Cell Biol.
7:310-318[CrossRef][Medline].
|
| 17.
|
Moroianu, J.,
G. Blobel, and A. Radu.
1997.
RanGTP-mediated nuclear export of karyopherin alpha involves its interaction with the nucleoporin Nup153.
Proc. Natl. Acad. Sci. USA
94:9699-9704[Abstract/Free Full Text].
|
| 18.
|
Nigg, E. A.
1997.
Nucleocytoplasmic transport: signals, mechanisms and regulation.
Nature
386:779-787[CrossRef][Medline].
|
| 19.
|
Orend, G.,
T. Hunter, and E. Ruoslahti.
1998.
Cytoplasmic displacement of cyclin E-Cdk2 inhibitors p21Cip1 and p27Kip1 in anchorage-independent cells.
Oncogene
16:2575-2583[CrossRef][Medline].
|
| 20.
|
Pante, N., and U. Aebi.
1994.
Toward the molecular details of the nuclear pore complex.
J. Struct. Biol.
113:179-189[CrossRef][Medline].
|
| 21.
|
Pines, J.
1999.
Four-dimensional control of the cell cycle.
Nat. Cell Biol.
1:E73-E79[CrossRef][Medline].
|
| 22.
|
Reynisdottir, I., and J. Massague.
1997.
The subcellular locations of p15(Ink4b) and p27(Kip1) coordinate their inhibitory interactions with Cdk4 and Cdk2.
Genes Dev.
11:492-503[Abstract/Free Full Text].
|
| 23.
|
Schoenwolf, G. C., and J. L. Smith.
1990.
Mechanisms of neurulation: traditional viewpoint and recent advances.
Development
109:243-270[Abstract].
|
| 24.
|
Sheaff, R. J.,
M. Groudine,
M. Gordon,
J. M. Roberts, and B. E. Clurman.
1997.
Cyclin E-CDK2 is a regulator of p27Kip1.
Genes Dev.
11:1464-1478[Abstract/Free Full Text].
|
| 25.
|
Sherr, C. J., and J. M. Roberts.
1999.
CDK inhibitors: positive and negative regulators of G1-phase progression.
Genes Dev.
13:1501-1512[Free Full Text].
|
| 26.
|
Singh, S. P.,
J. Lipman,
H. Goldman,
F. H. Ellis, Jr.,
L. Aizenman,
M. G. Cangi,
S. Signoretti,
D. S. Chiaur,
M. Pagano, and M. Loda.
1998.
Loss or altered subcellular localization of p27 in Barrett's associated adenocarcinoma.
Cancer Res.
58:1730-1735[Abstract/Free Full Text].
|
| 27.
|
Smith, J. L., and G. C. Schoenwolf.
1997.
Neurulation: coming to closure.
Trends Neurosci.
20:510-517[CrossRef][Medline].
|
| 28.
|
Stade, K.,
C. S. Ford,
C. Guthrie, and K. Weis.
1997.
Exportin 1 (Crm1p) is an essential nuclear export factor.
Cell
90:1041-1050[CrossRef][Medline].
|
| 29.
|
Sukegawa, J., and G. Blobel.
1993.
A nuclear pore complex protein that contains zinc finger motifs, binds DNA, and faces the nucleoplasm.
Cell
72:29-38[CrossRef][Medline].
|
| 30.
|
Tomoda, K.,
Y. Kubota, and J. Kato.
1999.
Degradation of the cyclin-dependent-kinase inhibitor p27Kip1 is instigated by Jab1.
Nature
398:160-165[CrossRef][Medline].
|
| 31.
|
Trichet, V.,
D. Shkolny,
I. Dunham,
D. Beare, and H. E. McDermid.
1999.
Mapping and complex expression pattern of the human NPAP60L nucleoporin gene.
Cytogenet. Cell Genet.
85:221-226[CrossRef][Medline].
|
| 32.
|
Ullman, K. S.,
M. A. Powers, and D. J. Forbes.
1997.
Nuclear export receptors: from importin to exportin.
Cell
90:967-970[CrossRef][Medline].
|
| 33.
|
Ullman, K. S.,
S. Shah,
M. A. Powers, and D. J. Forbes.
1999.
The nucleoporin nup153 plays a critical role in multiple types of nuclear export.
Mol. Biol. Cell
10:649-964[Abstract/Free Full Text].
|
| 34.
|
van Deursen, J.,
J. Boer,
L. Kasper, and G. Grosveld.
1996.
G2 arrest and impaired nucleocytoplasmic transport in mouse embryos lacking the proto-oncogene CAN/Nup214.
EMBO J.
15:5574-5583[Medline].
|
| 35.
|
Vojtek, A. B., and S. M. Hollenberg.
1995.
Ras-Raf interaction: two-hybrid analysis.
Methods Enzymol.
255:331-342[Medline].
|
| 36.
|
Yang, J.,
E. S. Bardes,
J. D. Moore,
J. Brennan,
M. A. Powers, and S. Kornbluth.
1998.
Control of cyclin B1 localization through regulated binding of the nuclear export factor CRM1.
Genes Dev.
12:2131-2143[Abstract/Free Full Text].
|
| 37.
|
Yang, J., and S. Kornbluth.
1999.
All aboard the cyclin train: subcellular trafficking of cyclins and their CDK partners.
Trends Cell Biol.
9:207-210[CrossRef][Medline].
|
Molecular and Cellular Biology, August 2000, p. 5631-5642, Vol. 20, No. 15
0270-7306/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Doufexis, M., Storr, H. L., King, P. J., Clark, A. J. L.
(2007). Interaction of the melanocortin 2 receptor with nucleoporin 50: evidence for a novel pathway between a G-protein-coupled receptor and the nucleus. FASEB J.
21: 4095-4100
[Abstract]
[Full Text]
-
Terry, L. J., Shows, E. B., Wente, S. R.
(2007). Crossing the Nuclear Envelope: Hierarchical Regulation of Nucleocytoplasmic Transport. Science
318: 1412-1416
[Abstract]
[Full Text]
-
Ball, J. R., Dimaano, C., Bilak, A., Kurchan, E., Zundel, M. T., Ullman, K. S.
(2007). Sequence Preference in RNA Recognition by the Nucleoporin Nup153. J. Biol. Chem.
282: 8734-8740
[Abstract]
[Full Text]
-
Borriello, A., Cucciolla, V., Criscuolo, M., Indaco, S., Oliva, A., Giovane, A., Bencivenga, D., Iolascon, A., Zappia, V., Della Ragione, F.
(2006). Retinoic Acid Induces p27Kip1 Nuclear Accumulation by Modulating Its Phosphorylation.. Cancer Res.
66: 4240-4248
[Abstract]
[Full Text]
-
Shin, I., Rotty, J., Wu, F. Y., Arteaga, C. L.
(2005). Phosphorylation of p27Kip1 at Thr-157 Interferes with Its Association with Importin {alpha} during G1 and Prevents Nuclear Re-entry. J. Biol. Chem.
280: 6055-6063
[Abstract]
[Full Text]
-
Moeller, S. J., Head, E. D., Sheaff, R. J.
(2003). p27Kip1 Inhibition of GRB2-SOS Formation Can Regulate Ras Activation. Mol. Cell. Biol.
23: 3735-3752
[Abstract]
[Full Text]
-
Hase, M. E., Cordes, V. C.
(2003). Direct Interaction with Nup153 Mediates Binding of Tpr to the Periphery of the Nuclear Pore Complex. Mol. Biol. Cell
14: 1923-1940
[Abstract]
[Full Text]
-
Salesse, S., Verfaillie, C. M.
(2003). BCR/ABL-mediated Increased Expression of Multiple Known and Novel Genes That May Contribute to the Pathogenesis of Chronic Myelogenous Leukemia. Molecular Cancer Therapeutics
2: 173-182
[Abstract]
[Full Text]
-
Kunzler, M., Hurt, E.
(2002). Targeting of Ran: variation on a common theme?. J. Cell Sci.
114: 3233-3241
[Abstract]
[Full Text]
-
Dilworth, D. J., Suprapto, A., Padovan, J. C., Chait, B. T., Wozniak, R. W., Rout, M. P., Aitchison, J. D.
(2001). Nup2p Dynamically Associates with the Distal Regions of the Yeast Nuclear Pore Complex. JCB
153: 1465-1478
[Abstract]
[Full Text]
-
Guan, T., Kehlenbach, R. H., Schirmer, E. C., Kehlenbach, A., Fan, F., Clurman, B. E., Arnheim, N., Gerace, L.
(2000). Nup50, a Nucleoplasmically Oriented Nucleoporin with a Role in Nuclear Protein Export. Mol. Cell. Biol.
20: 5619-5630
[Abstract]
[Full Text]
-
Tomoda, K., Kubota, Y., Arata, Y., Mori, S., Maeda, M., Tanaka, T., Yoshida, M., Yoneda-Kato, N., Kato, J.-y.
(2002). The Cytoplasmic Shuttling and Subsequent Degradation of p27Kip1 Mediated by Jab1/CSN5 and the COP9 Signalosome Complex. J. Biol. Chem.
277: 2302-2310
[Abstract]
[Full Text]